The NOD/SCID/IL2Rγ−/− (NSG) mouse was selected as the background strain for these studies because of its lack of endogenous immune killing mechanisms by ADCC (natural killer (NK) and myeloid cells) and CDC activity [35], and its high rate of xenogenic tumor engraftment [27]. The gene discussed is IL2RG; the disease is neoplasm.